LC
GBIO

Lindbrook Capital’s Generation Bio GBIO Stock Holding History

Lindbrook Capital’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28
Closed -$1.75K – 2725
2022
Q2 		$2K Buy
+28
New +$1.83K ﹤0.01% 1960

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lindbrook Capital's GBIO Position: Q3 2022 in Review

Lindbrook Capital sold out of Generation Bio (GBIO) in Q3 2022, closing a stake of 28 shares — an estimated $1.75K sold.

Lindbrook Capital first reported a position in GBIO in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 111 funds tracked by Wall St. Rank hold GBIO as of Q3 2022.

  • Lindbrook Capital reported no remaining Generation Bio position as of Q3 2022 after selling out during the quarter.
  • Lindbrook Capital sold 28 Generation Bio shares in Q3 2022, an estimated $1.75K.
  • Lindbrook Capital first reported a position in Generation Bio in Q2 2022 and held it in 1 quarter.
  • Lindbrook Capital's Generation Bio position peaked at $2K in Q2 2022.
  • 111 funds tracked by Wall St. Rank held Generation Bio as of Q3 2022.

Based on Lindbrook Capital's 13F filing for Q3 2022, filed 10 Nov 2022.